Christopher R. Fenimore - Net Worth and Insider Trading
Christopher R. Fenimore Net Worth
The estimated net worth of Christopher R. Fenimore is at least $22 Million dollars as of 2024-04-27. Christopher R. Fenimore is the SVP Finance & CFO of Regeneron Pharmaceuticals Inc and owns about 24,431 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $22 Million. Details can be seen in Christopher R. Fenimore's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher R. Fenimore has not made any transactions after 2024-02-09 and currently still holds the listed stock(s).
Transaction Summary of Christopher R. Fenimore
Christopher R. Fenimore Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher R. Fenimore owns 1 companies in total, including Regeneron Pharmaceuticals Inc (REGN) .
Click here to see the complete history of Christopher R. Fenimore’s form 4 insider trades.
Insider Ownership Summary of Christopher R. Fenimore
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-02-09 | VP & Controller |
Christopher R. Fenimore Latest Holdings Summary
Christopher R. Fenimore currently owns a total of 1 stock. Christopher R. Fenimore owns 24,431 shares of Regeneron Pharmaceuticals Inc (REGN) as of February 9, 2024, with a value of $22 Million.
Latest Holdings of Christopher R. Fenimore
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals Inc | 2024-02-09 | 24,431 | 883.20 | 21,577,459 |
Holding Weightings of Christopher R. Fenimore
Christopher R. Fenimore Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher R. Fenimore has made a total of 11 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 4,919 shares on February 9, 2024, which brought Christopher R. Fenimore around $5 Million.
Insider Trading History of Christopher R. Fenimore
- 1
Christopher R. Fenimore Trading Performance
Christopher R. Fenimore Ownership Network
Ownership Network List of Christopher R. Fenimore
Ownership Network Relation of Christopher R. Fenimore
Christopher R. Fenimore Owned Company Details
What does Regeneron Pharmaceuticals Inc do?
Who are the key executives at Regeneron Pharmaceuticals Inc?
Christopher R. Fenimore is the VP & Controller of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , EVP Research Andrew J Murphy , and SVP Gen Counsel & Secretary Joseph J Larosa .
Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary
Over the past 18 months, Christopher R. Fenimore made 4 insider transaction in Regeneron Pharmaceuticals Inc (REGN) with a net sale of 11,489. Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 10,816 shares made by Marion Mccourt , a net sale of 1,300 shares made by Arthur F Ryan , and a net sale of 7,302 shares made by Bonnie L Bassler .
In summary, during the past 3 months, insiders sold 41,262 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 41,262 shares. During the past 18 months, 198,549 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 198,549 shares.
Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regeneron Pharmaceuticals Inc Insider Transactions
Christopher R. Fenimore Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher R. Fenimore. You might contact Christopher R. Fenimore via mailing address: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown Ny 10591.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
